Catalyst Wire Dossier Catalyst Wire Dossier

CHILDRENS IBUPROFEN

IBUPROFEN · Chain Drug Marketing Association Inc.
Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for CHILDRENS IBUPROFEN, covering 2017-06-27 to 2026-08-26. Get the full timeline:

Most recent: FDA Approved: CHILDRENS IBUPROFEN — Supplemental Application (Chain Drug Marketing Association Inc.)

See pricing